Baird: Prospects For Proteostasis Therapeutics' PTI-428 Are Not Priced Into The Stock
March 16, 2018 at 10:59 AM EDT
Even after Wednesday’s 31-percent run, a Baird analyst forecast 300-percent upside to Proteostasis Therapeutics Inc (NASDAQ: ...
